Company Information

  

Address: 101 HARTWELL AVENUE  
City: LEXINGTON 
State: MA 
Zip Code: 02421 
Telephone: 781-457-1200 

Description of Business

Primary SIC Code: 3841
(As filed with the SEC)  

We are an in vitro diagnostics company that has developed an innovative and proprietary technology platform that offers a rapid, sensitive and simple alternative to existing diagnostic methodologies. We are using our T2 Magnetic Resonance technology, or T2MR, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. T2MR enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as low as one colony forming unit per milliliter, or CFU/mL. Our initial development efforts target sepsis and Lyme disease, which are areas of significant unmet medical need in which existing therapies could be more effective with improved diagnostics.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
03/2018-1.82NAN/E
12/2017-1.94NAN/E
09/2017-1.90NAN/E
06/2017-1.97NAN/E
03/2017-2.04NAN/E
12/2016-2.11NAN/E
09/2016-2.21NAN/E
06/2016-2.27NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity-0.23Total Liab/Total Assets0.98
Net Inc/Total Assets-1.14Total Liab/Inv Cap-1.34
Net Inc/Inv Cap1.57Total Liab/Comm Equity0.20
Pretax Inc/Net Sales-13.38Interest Coverage Ratio-6.01
Net Inc/Net Sales-13.38Curr Debt/Equity32.04
Cash Flow/Net Sales-10.23LTD/Equity0.75
SG&A/NetSales4.88Total Debt/Equity32.79
Asset Utilization   Liquidity  
Net Receivables Turnover11.75Quick Ratio0.83
Inventory Turnover11.20Current Ratio0.86
Inventory Day Sales0.02Net Rec/Curr Assets0.01
Net Sales/Work Cap-0.63Inv/Curr Assets0.03
Net Sales/PP&E0.47  

Income Statement (Millions)

  3/31/2018 12/31/2017 9/30/2017 6/30/2017
Total Revenues(Net Sales) 2.31 1.66 1.11 0.96
Cost of Goods Sold 3.27 6.31 2.11 1.99
Selling & Admin Exps 5.76 5.57 5.56 5.76
Operating Income -11.44 -14.37 -12.44 -13.91
Interest Exp 1.57 3.90 1.72 1.65
Pretax Income -12.91 -18.19 -14.07 -15.46
Other Income 0.09 0.07 0.08 0.10
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -12.91 -18.19 -14.07 -15.46

Balance Sheet (Millions)

Assets 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Cash & Short Term Investments 29.73 41.80 52.90 46.13
Receivables - Total 0.58 0.47 0.44 0.98
Inventories - Total 2.08 1.34 1.25 1.01
Total Current Assets 33.02 44.32 55.35 48.79
Net Property, Plant & Equipment 8.71 10.02 13.85 14.51
Total Assets 42.12 54.86 69.68 63.78
Liabilities        
Accounts Payable 6.39 6.87 6.51 6.36
Debt in Current Liabilities 43.40 42.93 1.42 1.37
Total Current Liabilities 50.92 51.78 10.25 10.47
Long-Term Debt 0.61 1.01 40.09 39.91
Total Liabilities 52.21 53.52 51.55 51.45
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 0.04 0.04 0.04 0.03
Retained Earnings -278.93 -266.12 -247.92 -233.85
Treasury Stock NA NA NA NA
Total Stockholders' Equity -10.09 1.34 18.13 12.33
Total Liabilities and Stockholders' Equity 42.12 54.86 69.68 63.78

Cash Flow Summary (Millions)

Categories 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Net Cash Provided by Operating Activities -11.74 -11.08 -11.66 -12.22
Net Cash Provided by Investing Activities -0.06 0.13 -0.13 -0.87
Net Cash Provided by Financing Activities -0.35 -0.15 18.56 0.41

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20130.27-20.61--
12/20140.12-31.39-4.15
12/20152.81-45.29-2.21
12/20164.08-54.80-2.11
12/20174.67-62.43-1.94
Growth Rates104.65----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional03/31/185918,76543.61




Report Date : 6/11/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.